微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -1.26% | -280% | -12700% | 39/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 0.01% | -98.21% | -92.31% | 37/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 0.13% | -69.05% | -86.02% | 33/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 0.93% | -87.47% | 32.86% | 36/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 0.7% | -91.04% | 25% | 40/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 0.56% | -90.39% | 33.33% | 37/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 0.42% | -88.17% | -94.34% | 35/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 7.42% | -53.86% | -4.99% | 26/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 7.81% | -53.65% | 33.96% | 25/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 5.83% | -53.88% | 64.23% | 18/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 3.55% | -49.21% | -77.92% | 16/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 16.08% | -59.43% | -4.57% | 16/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 16.85% | -65.27% | 33.31% | 9/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 12.64% | -59.54% | 80.83% | 9/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 6.99% | 119.12% | -82.37% | 6/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 39.64% | 688.07% | -18.3% | 4/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 48.52% | 666.51% | 55.31% | 1/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 31.24% | 642.04% | 879.31% | 1/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 3.19% | 36.91% | -36.58% | 5/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 5.03% | -31.28% | -20.54% | 36/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 6.33% | -16.05% | 50.36% | 16/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 4.21% | 5.78% | 80.69% | 16/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 2.33% | -3.32% | -68.17% | 10/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 7.32% | -15.28% | -2.92% | 28/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 7.54% | -13.23% | 89.45% | 14/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 3.98% | -17.08% | 65.15% | 14/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 2.41% | 7.11% | -72.11% | 9/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 8.64% | 16.76% | -0.58% | 21/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 8.69% | 2% | 81.04% | 13/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 4.8% | 96.72% | 113.33% | 13/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 2.25% | 2% | -69.59% | 11/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 7.4% | 14.2% | 14.2% | 21/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2015-12-31 | 6.48% | 127.37% | 165.57% | 24/51 | 22.23% | 南华生物 | 383.03% | 行业排名> |
| 2015-06-30 | 2.44% | 2% | -14.39% | 12/51 | -30.81% | *ST宜康 | 36.84% | 行业排名> |